As on February 08, 2021, Seneca Biopharma Inc. (NASDAQ: SNCA) got off with the flyer as it spiked 18.49% to $1.73. During the day, the stock rose to $1.92 and sunk to $1.51 before settling in for the price of $1.46 at the close. Taking a more long-term approach, SNCA posted a 52-week range of $0.50-$2.10.
Meanwhile, its Annual Earning per share during the time was 43.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 41.50%. This publicly-traded company’s shares outstanding now amounts to $17.31 million, simultaneously with a float of $17.16 million. The organization now has a market capitalization sitting at $29.74 million. At the time of writing, stock’s 50-day Moving Average stood at $1.0631, while the 200-day Moving Average is $0.8066.
It is quite necessary to find out the efficiency of the corporate organization, which has 5 number of employees on its payroll. It has generated 3,079 per worker during the last fiscal year. Meanwhile, its income per employee was -1,670,330. The stock had 0.08 Receivables turnover and 0.00 Total Asset turnover. For the Profitability, stocks operating margin was -56071.81 and Pretax Margin of -54252.64.
Seneca Biopharma Inc. (SNCA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Seneca Biopharma Inc.’s current insider ownership accounts for 0.82%, in contrast to 12.70% institutional ownership.
Seneca Biopharma Inc. (SNCA) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 6/29/2017, the company posted -$7.2 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$14.6) by $7.4. This company achieved a net margin of -54252.64 while generating a return on equity of -149.46. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Seneca Biopharma Inc.’s EPS increase for this current 12-month fiscal period is 41.50%.
Seneca Biopharma Inc. (NASDAQ: SNCA) Trading Performance Indicators
Let’s observe the current performance indicators for Seneca Biopharma Inc. (SNCA). It’s Quick Ratio in the last reported quarter now stands at 15.00. The Stock has managed to achieve an average true range (ATR) of 0.19. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2199.61.
In the same vein, SNCA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.64.
Technical Analysis of Seneca Biopharma Inc. (SNCA)
Through scrutinizing the latest numbers posted by the [Seneca Biopharma Inc., SNCA], it can be observed that its last 5-days Average volume of 3.16 million was lower the volume of 4.12 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 49.61% While, its Average True Range was 0.1907.
Raw Stochastic average of Seneca Biopharma Inc. (SNCA) in the period of the previous 100 days is set at 86.62%, which indicates a major rise in contrast to 71.64% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 122.10% that was higher than 96.63% volatility it exhibited in the past 100-days period.